Biolargo Inc. (BLGO) 0.3121 $BLGO
BioLargo's Odor-No-More Awarded Exclusive Supplier Contract From the Defense Logistics Agency
Marketwired - Wed Mar 18, 8:01AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced today that its Odor-No-More subsidiary, through its distributor Downeast Logistics, was awarded a $150,000 "Indefinite Delivery Purchase Order" (IDPO) for its Specimen Transport Solidifier pouches by the U.S. Defense Logistics Agency (DLA). The purchase order allows the DLA to purchase the product at agreed-upon prices for the following 12 months. In exchange, the company is awarded the contract to be the exclusive supplier of the designated product under the IDPO. The DLA has the option to expand the maximum award up to $300,000 for the year.
BioLargo's AOS Filter Lands Its First Canadian Federal Research Grant
Marketwired - Thu Jan 22, 8:03AM CST
BioLargo, Inc. (OTCQB: BLGO) announced today that the Natural Sciences and Engineering Research Council of Canada (NSERC) has awarded an "Engage Grant" to Dr. Lynn McMullen at the University of Alberta's Department of Agriculture, Food and Nutritional Sciences to initiate research with BioLargo's Canadian subsidiary BioLargo Water, Inc. The grant will allow dedicated research at the University of Alberta around the company's AOS Filter technology and its electrochemical inactivation of pathogens. This research will provide the necessary fundamental data that can be translated to further applications in the food and agricultural industries.
BioLargo Issued Patent for Its Platform of Liquid and Hydrogel Iodine Technologies
Marketwired - Wed Nov 12, 12:59PM CST
BioLargo, Inc. (OTCQB: BLGO) announced today the United States Patent and Trademark Office issued patent 8,846,067 titled "antimicrobial solutions and methods" which covers the use of BioLargo's iodine technology in its platform of liquid and hydrogel solutions. The liquid and gel technologies are foundational to multiple products sold under various brands by BioLargo's subsidiary companies, including Nature's Best Solution, NBS, Odor-No-More, and Deodorall. The new patent also covers the wound gel and wound cleanser products in final stages of development at BioLargo subsidiary Clyra Medical Technologies, Inc., being readied for application for FDA approval and licensure. The patent also covers other liquid and gel products in development for disinfection (such as to control bacteria, fungi, spores and viruses), as well as odor control. Additionally, the patent covers the potential use of the company's hydrogel when combined with boron to provide a barrier/absorption technology for radiation leaks.
BioLargo's AOS Filter Receives Coveted Technology Star Award
Marketwired - Mon Nov 10, 8:04AM CST
BioLargo, Inc. (OTCQB: BLGO) announced today its AOS Filter had been named the best "Health, Safety & Environment" technology by the editorial staff at the Calgary based oil industry trade publication New Technology Magazine. It is featured in its annual "Technology Stars" fall awards.
BioLargo Achieves Major Milestone -- Advancing Its AOS Filter Towards Commercialization
Marketwire - Mon Sep 29, 8:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced that scientists at the University of Alberta Department of Agricultural, Food and Nutritional Science tested and validated its Advanced Oxidation System (AOS) Filter for use in food and agriculture. This work follows on the heels of validation work by the University of Alberta's Department of Engineering for its use in eliminating soluble organic contaminants like those found in oil sands tailings ponds.
BioLargo's Odor-No-More Gains More Traction With Its Largest Government Order to Date
Marketwire - Tue Sep 23, 8:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced today its Odor-No-More subsidiary was awarded a contract for 885 cases (total order approximately $50,000) of its Specimen Transport Solidifier Pouches from the DLA U.S. Defense Logistics Agency (DLA - www.dla.mil), through its distributor Downeast Logistics. The Specimen Transport Solidifiers are small absorbent pouches containing BioLargo's patent-protected technology and sold under the "NBS" brand. They and are used by the military as a safety measure in the event of a spill during the transport of blood, urine and other hazardous medical liquids. The company is producing the products for the order, and plans to fulfill the order in early October. This is the largest of many small orders from the DLA.
BioLargo to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Marketwire - Wed Aug 20, 7:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) will present at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, September 9th at the New York Palace Hotel. Dennis Calvert, BioLargo's president, is scheduled to present at 2:55 p.m. ET.
BioLargo Enters Into Agreement to Bring Its Isan System to Market
Marketwire - Mon Aug 18, 7:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) entered into a manufacturing and distribution license agreement for its Isan(R) system with Clarion Water, a new operating division of InsulTech Manufacturing, LLC (www.insultech.com), the latter of which has over 20 years of commercial success around the globe representing hundreds of millions in sales of technical products to Fortune 100 companies.
BioLargo Strengthens Intellectual Property Portfolio With Two New U.S. Patents
Marketwire - Tue Jul 01, 7:01AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced it was issued two new patents by the United States Patent and Trademark Office ("USPTO"
further strengthening its growing patent portfolio and demonstrating multiple technical fields for application of the company's advanced iodine platform technology.
BioLargo's Odor-No-More Awarded Exclusive Supplier Contract From the Defense Logistics Agency
Marketwired - Wed Mar 18, 8:01AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced today that its Odor-No-More subsidiary, through its distributor Downeast Logistics, was awarded a $150,000 "Indefinite Delivery Purchase Order" (IDPO) for its Specimen Transport Solidifier pouches by the U.S. Defense Logistics Agency (DLA). The purchase order allows the DLA to purchase the product at agreed-upon prices for the following 12 months. In exchange, the company is awarded the contract to be the exclusive supplier of the designated product under the IDPO. The DLA has the option to expand the maximum award up to $300,000 for the year.
BioLargo's AOS Filter Lands Its First Canadian Federal Research Grant
Marketwired - Thu Jan 22, 8:03AM CST
BioLargo, Inc. (OTCQB: BLGO) announced today that the Natural Sciences and Engineering Research Council of Canada (NSERC) has awarded an "Engage Grant" to Dr. Lynn McMullen at the University of Alberta's Department of Agriculture, Food and Nutritional Sciences to initiate research with BioLargo's Canadian subsidiary BioLargo Water, Inc. The grant will allow dedicated research at the University of Alberta around the company's AOS Filter technology and its electrochemical inactivation of pathogens. This research will provide the necessary fundamental data that can be translated to further applications in the food and agricultural industries.
BioLargo Issued Patent for Its Platform of Liquid and Hydrogel Iodine Technologies
Marketwired - Wed Nov 12, 12:59PM CST
BioLargo, Inc. (OTCQB: BLGO) announced today the United States Patent and Trademark Office issued patent 8,846,067 titled "antimicrobial solutions and methods" which covers the use of BioLargo's iodine technology in its platform of liquid and hydrogel solutions. The liquid and gel technologies are foundational to multiple products sold under various brands by BioLargo's subsidiary companies, including Nature's Best Solution, NBS, Odor-No-More, and Deodorall. The new patent also covers the wound gel and wound cleanser products in final stages of development at BioLargo subsidiary Clyra Medical Technologies, Inc., being readied for application for FDA approval and licensure. The patent also covers other liquid and gel products in development for disinfection (such as to control bacteria, fungi, spores and viruses), as well as odor control. Additionally, the patent covers the potential use of the company's hydrogel when combined with boron to provide a barrier/absorption technology for radiation leaks.
BioLargo's AOS Filter Receives Coveted Technology Star Award
Marketwired - Mon Nov 10, 8:04AM CST
BioLargo, Inc. (OTCQB: BLGO) announced today its AOS Filter had been named the best "Health, Safety & Environment" technology by the editorial staff at the Calgary based oil industry trade publication New Technology Magazine. It is featured in its annual "Technology Stars" fall awards.
BioLargo Achieves Major Milestone -- Advancing Its AOS Filter Towards Commercialization
Marketwire - Mon Sep 29, 8:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced that scientists at the University of Alberta Department of Agricultural, Food and Nutritional Science tested and validated its Advanced Oxidation System (AOS) Filter for use in food and agriculture. This work follows on the heels of validation work by the University of Alberta's Department of Engineering for its use in eliminating soluble organic contaminants like those found in oil sands tailings ponds.
BioLargo's Odor-No-More Gains More Traction With Its Largest Government Order to Date
Marketwire - Tue Sep 23, 8:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced today its Odor-No-More subsidiary was awarded a contract for 885 cases (total order approximately $50,000) of its Specimen Transport Solidifier Pouches from the DLA U.S. Defense Logistics Agency (DLA - www.dla.mil), through its distributor Downeast Logistics. The Specimen Transport Solidifiers are small absorbent pouches containing BioLargo's patent-protected technology and sold under the "NBS" brand. They and are used by the military as a safety measure in the event of a spill during the transport of blood, urine and other hazardous medical liquids. The company is producing the products for the order, and plans to fulfill the order in early October. This is the largest of many small orders from the DLA.
BioLargo to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Marketwire - Wed Aug 20, 7:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) will present at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, September 9th at the New York Palace Hotel. Dennis Calvert, BioLargo's president, is scheduled to present at 2:55 p.m. ET.
BioLargo Enters Into Agreement to Bring Its Isan System to Market
Marketwire - Mon Aug 18, 7:02AM CDT
BioLargo, Inc. (OTCQB: BLGO) entered into a manufacturing and distribution license agreement for its Isan(R) system with Clarion Water, a new operating division of InsulTech Manufacturing, LLC (www.insultech.com), the latter of which has over 20 years of commercial success around the globe representing hundreds of millions in sales of technical products to Fortune 100 companies.
BioLargo Strengthens Intellectual Property Portfolio With Two New U.S. Patents
Marketwire - Tue Jul 01, 7:01AM CDT
BioLargo, Inc. (OTCQB: BLGO) announced it was issued two new patents by the United States Patent and Trademark Office ("USPTO"
further strengthening its growing patent portfolio and demonstrating multiple technical fields for application of the company's advanced iodine platform technology. 
